| Group 1 mould exposed | Group 2 atopic | Group 3 controls |
Subjects n | 13 | 5 | 10 |
Age yrs | 48 (40–56) | 43 (30–60) | 42 (27–57) |
Smoking status | | | |
Current smoker | 0 | 1 | 0 |
Ex-smoker | 2 | 1 | 2 |
Positive skin-prick tests | | | |
Basic series or storage mites | 5 | 5 | 0 |
Moulds | 1# | 0 | 0 |
Serum levels IU·L−1 | | | |
Total IgE* | 57.8 (9.3–112.0) | 247.7 (52.2–757.0) | 71.4 (6.3–395.0) |
ECP levels | 14.5 (5.4–26.3) | 15.9 (8.0–40.9) | 17.9 (7.4–34.4) |
Lung function | | | |
FEV1 L¶ | 2.78 (96) | 3.56 (105) | 3.44 (108) |
FVC L* | 3.37 (95) | 4.16 (100) | 3.95 (103) |
Diffusion capacity¶ mmol·min−1·kPa−1 | 8.7 (116) | 11.9 (138) | 9.3 (120) |